XML 79 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity
 3 Months Ended
Mar. 31, 2014
Equity [Abstract]  
Equity
Note 14 — Equity
Common Stock
On October 31, 2013, we announced that Ocwen’s Board of Directors had authorized a share repurchase program for an aggregate of up to $500.0 million of Ocwen’s issued and outstanding shares of common stock. Repurchases may be made in open market transactions at prevailing market prices or in privately negotiated transactions. Unless we amend the share repurchase program or repurchase the full $500.0 million amount by an earlier date, the share repurchase program will continue through July 2016. No assurances can be given as to the amount of shares, if any, that we may repurchase in any given period. The repurchase of shares issued in connection with the conversion of our Series A Perpetual Convertible Preferred Stock (the Preferred Shares) is not considered to be part of this repurchase program and, therefore, does not count against the $500.0 million aggregate value limit. During the three months ended March 31, 2014, we completed the repurchase of 60,000 shares of common stock in the open market under this program for a total purchase price of $2.3 million. Through March 31, 2014, we have completed the repurchase of 1,185,707 total shares of common stock under this program for an aggregate purchase price of $62.3 million. See Note 22 - Subsequent Events for information regarding repurchases completed subsequent to March 31, 2014.
Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss (AOCL), net of income taxes, were as follows at the dates indicated:
 
March 31, 2014
 
December 31, 2013
Unrealized losses on cash flow hedges
$
9,418

 
$
10,026

Other
124

 
125

 
$
9,542

 
$
10,151


See Note 15 — Derivative Financial Instruments and Hedging Activities for the changes in the components of AOCL for the three months ended March 31, 2014 and 2013.